Product Information
BUSPIRONE HCL 5 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0219 per EA under NDC 59651038905. Its NADAC has been published 253 times since Aug 25, 2021.
Strength
5 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651038905
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
BUSPIRONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078246On Market Since
2/21/2020
Price Statistics
The NADAC for BUSPIRONE HCL 5 MG TABLET has been published 253 times since Aug 25, 2021, and over the history we have for it it has declined 17.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0219 per EA |
|---|---|
| All-time high | $0.0314 (Nov 16, 2022) |
| All-time low | $0.0174 (Nov 20, 2024) |
| 52-week high | $0.0232 |
| 52-week low | $0.0214 |
| Median price | $0.0250 |
| Average price | $0.0249 |
| Largest weekly change | -25.2% (Nov 20, 2024) |
| Weeks tracked | 253 |
| Tracking since | Aug 25, 2021 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BUSPIRONE HCL 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUSPIRONE HCL 5 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.0219 per EA (NDC 59651038905), effective Jun 24, 2026.
How has the price of BUSPIRONE HCL 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUSPIRONE HCL 5 MG TABLET has declined 17.8%. It has been tracked across 253 weekly CMS publications since Aug 25, 2021.
What are the highest and lowest recorded NADAC prices for BUSPIRONE HCL 5 MG TABLET?
Since Aug 25, 2021, the NADAC for BUSPIRONE HCL 5 MG TABLET has ranged from a low of $0.0174 (Nov 20, 2024) to a high of $0.0314 (Nov 16, 2022), with a median of $0.0250 per EA.
Are there cheaper alternatives to BUSPIRONE HCL 5 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as BUSPIRONE HCL 5 MG TABLET, but none are currently priced below it.
Who manufactures BUSPIRONE HCL 5 MG TABLET?
BUSPIRONE HCL 5 MG TABLET (NDC 59651038905) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification